source
- FDA advisory panel backs broader use of wellness peptide BPC-157 despite internal concernsThe FDA advisory committee voted Thursday to recommend loosening restrictions on BPC-157, a peptide popular among health and wellness enthusiasts for muscle repair, injury healing, metabolism suppo…
- Repligen to acquire BioLife Solutions for $1.5 billion as BeOne announces $300 million US expansionRepligen announced it will acquire cell‑processing services provider BioLife Solutions in a transaction valued at roughly $1.5 billion. The deal adds BioLife’s platform to Repligen’s portfolio of b…